Oscar Alabiso
Novara, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Multicenter Single-Arm, Two-Stage Phase 2 Study of Panitumumab in Patients With Cetuximab-Refractory Metastatic Colorectal Cancer: The PACER Trial.
Journal: Clinical colorectal cancer
Published: June 03, 2019
Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations.
Journal: British journal of cancer
Published: May 12, 2018
Integrins in T Cell Physiology.
Journal: International journal of molecular sciences
Published: December 24, 2017
MMC/UFT/LV in refractory colorectal cancer: phase II study and analysis of predictive variables of progression.
Journal: International journal of clinical oncology
Published: May 18, 2017
Port in oncology practice: 3-monthly locking with normal saline for catheter maintenance, a preliminary report.
Journal: The journal of vascular access
Published: March 29, 2017
Resveratrol inhibits IL-6-induced ovarian cancer cell migration through epigenetic up-regulation of autophagy.
Journal: Molecular carcinogenesis
Published: July 25, 2016
Observational study on quality of life, safety, and effectiveness of first-line cetuximab plus chemotherapy in KRAS wild-type metastatic colorectal cancer patients: the ObservEr Study.
Journal: Cancer medicine
Published: May 04, 2016
Economic burden of patients affected by non-small cell lung cancer (NSCLC): the LIFE study.
Journal: Journal of cancer research and clinical oncology
Published: April 11, 2016
Comparison of the Tolerability Profile of Controlled-Release Oral Morphine and Oxycodone for Cancer Pain Treatment. An Open-Label Randomized Controlled Trial.
Journal: Journal of pain and symptom management
Published: February 29, 2016
Circannual variation of efficacy outcomes in patients with newly diagnosed metastatic colorectal cancer and treated with first-line chemotherapy.
Journal: Chronobiology international
Published: November 06, 2015
Docetaxel plus androgen deprivation withdrawal may restore sensitivity to luteinizing hormone-releasing hormone analog therapy in castration-resistant prostate cancer patients.
Journal: Endocrine
Published: September 09, 2015
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 28, 2015
Last Updated: 09/26/2026